1 / 6

Migraine Drugs Market - Global Opportunity Analysis and Industry Forecast, 2018-2025

Surge in awareness about migraine treatment and prevention across the globe is anticipated to significantly drive the growth of the migraine drugs market. Furthermore, rise in female population worldwide is the key factor that augments the market growth.t

sandeeps88
Download Presentation

Migraine Drugs Market - Global Opportunity Analysis and Industry Forecast, 2018-2025

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Fraud Detection & Prevention Markt Sensing DTS Market Market Memristor Market et Migraine Drugs Market  Global Opportunity Analysis and Industry Forecast To 2023 Global Opportunity Analysis & Industry Forecast, 2014-2022 Opportunity Analysis and Industry Forecast, 2014 - 2022 Global Opportunity Analysis and Industry Forecast, 2014-2022 Opportunity Analysis and Industry Forecast, 2014-2022 Global Opportunity Analysis and Industry Forecast 2023 Global Opportunity Analysis and Industry Forecast, 2014-2022 Global Opportunity Analysis and Industry Forecast, 2014 - 2022 Global Opportunity Analysis and Industry Forecast, 2017-2023 Global Opportunity Analysis and Industry Forecast 2018-2025 Pages:225 Tables:119 Charts:46

  2. Migraine Drugs Market Severe headache in one particular area that can vary in intensity and slight dizziness are the prime symptoms of migraine. About 13% of Americans (about 38 million people) suffer from migraine and most importantly, every patient has a different experience of this condition. Thus, there is a dire need for personalized treatment rather than a common drug for every patient. Unfortunately, such drug is not available in the market. This has boosted the R&D activities to develop a permanent cure for migraine, which has, in turn, propelled the growth of the migraine drug market. According to Allied Market Research, the global migraine drug market is projected to reach $2.19 billion by 2025, registering a compound annual growth rate (CAGR) of 3.1% during the period 2018–2025.

  3. Migraine Drugs Market By type, abortive medicines accounted for more than three-fourths share of the global migraine drugs market in 2017. Furthermore, by route of administration, the oral segment is anticipated to grow at the highest rate of 3.4% during the forecast period. North America was the leading revenue contributor to the global market in 2017, owing to surge in demand for better healthcare along with effective government reforms for awareness towards migraine & its prevention. However, Asia-Pacific is expected to grow at the highest CAGR of 4.4% from 2018 to 2025, due to improvements in healthcare infrastructure and rise in demand for better healthcare facilities. Download Sample @ https://www.alliedmarketresearch.com/request-sample/2811

  4. Migraine Drugs Market • Major Companies: • Abbott Laboratories • Allergan Plc. • AstraZeneca • Eisai Co. Ltd. • Endo International Plc. • GlaxoSmithKline Plc. • Impax Laboratories • Johnson & Johnson • Merck & Co. • Pfizer Inc.

  5. Migraine Drugs Market • Migraine Drugs Market Study Key Findings: • North America occupied two-fifths share of the global migraine drugs market. • Oral is anticipated to grow with the highest CAGR throughout the forecast period. • Europe is anticipated to occupy more than one-fourth market share of the global migraine drugs market by 2025. • Asia-Pacific is anticipated to grow at the highest rate during the analysis period, followed by LAMEA. • Have Queries? Ask us @ https://www.alliedmarketresearch.com/purchase-enquiry/2811

  6. Migraine Drugs Market • Contact: • David Correa • 5933 NE Win Sivers Drive • #205, Portland, OR 97220 • United States • Toll Free (USA/Canada): • +1-800-792-5285, +1-503-894-6022, +1-503-446-1141 • UK: +44-845-528-1300 • Hong Kong: +852-301-84916 • India (Pune): +91-20-66346060 • Fax: +1⟨855⟩550-5975 • help@alliedmarketresearch.com • Web: https://www.alliedmarketresearch.com

More Related